Kleinhenz M, Beesetty P, Yang C, Li Z, Montgomery C
Antimicrob Agents Chemother. 2022; 66(4):e0227021.
PMID: 35266822
PMC: 9017378.
DOI: 10.1128/aac.02270-21.
Lee S, Benoun J, Sheridan B, Fogassy Z, Pham O, Pham Q
J Immunol. 2017; 199(4):1353-1361.
PMID: 28710253
PMC: 5548602.
DOI: 10.4049/jimmunol.1601357.
Benoun J, Labuda J, McSorley S
mBio. 2016; 7(6).
PMID: 27999159
PMC: 5181774.
DOI: 10.1128/mBio.01520-16.
Macedo N, Rovira A, Torremorell M
Vet Res. 2015; 46:128.
PMID: 26511717
PMC: 4625873.
DOI: 10.1186/s13567-015-0263-3.
ODonnell H, Pham O, Benoun J, Ravesloot-Chavez M, McSorley S
Future Microbiol. 2015; 10(10):1615-27.
PMID: 26439708
PMC: 4942118.
DOI: 10.2217/fmb.15.93.
Direct visualization of endogenous Salmonella-specific B cells reveals a marked delay in clonal expansion and germinal center development.
Nanton M, Lee S, Atif S, Nuccio S, Taylor J, Baumler A
Eur J Immunol. 2014; 45(2):428-41.
PMID: 25346524
PMC: 4323875.
DOI: 10.1002/eji.201444540.
Immunity to intestinal pathogens: lessons learned from Salmonella.
McSorley S
Immunol Rev. 2014; 260(1):168-82.
PMID: 24942689
PMC: 4066191.
DOI: 10.1111/imr.12184.
A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.
Maue A, Poly F, Guerry P
Hum Vaccin Immunother. 2014; 10(6):1499-504.
PMID: 24632556
PMC: 5396224.
DOI: 10.4161/hv.27985.
Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge model.
Kirkpatrick B, Lyon C, Porter C, Maue A, Guerry P, Pierce K
Clin Infect Dis. 2013; 57(8):1106-13.
PMID: 23840001
PMC: 3888245.
DOI: 10.1093/cid/cit454.
Cutting edge: B cells are essential for protective immunity against Salmonella independent of antibody secretion.
Nanton M, Way S, Shlomchik M, McSorley S
J Immunol. 2012; 189(12):5503-7.
PMID: 23150714
PMC: 3518619.
DOI: 10.4049/jimmunol.1201413.
Extensive in vivo resilience of persistent Salmonella.
Barat S, Steeb B, Maze A, Bumann D
PLoS One. 2012; 7(7):e42007.
PMID: 22911873
PMC: 3404010.
DOI: 10.1371/journal.pone.0042007.
Drug treatment of malaria infections can reduce levels of protection transferred to offspring via maternal immunity.
Staszewski V, Reece S, ODonnell A, Cunningham E
Proc Biol Sci. 2012; 279(1737):2487-96.
PMID: 22357264
PMC: 3350664.
DOI: 10.1098/rspb.2011.1563.
Temporal expression of bacterial proteins instructs host CD4 T cell expansion and Th17 development.
Lee S, McLachlan J, Kurtz J, Fan D, Winter S, Baumler A
PLoS Pathog. 2012; 8(1):e1002499.
PMID: 22275869
PMC: 3262010.
DOI: 10.1371/journal.ppat.1002499.
Generation of Salmonella-specific Th1 cells requires sustained antigen stimulation.
Griffin A, McSorley S
Vaccine. 2011; 29(15):2697-704.
PMID: 21315116
PMC: 3051039.
DOI: 10.1016/j.vaccine.2011.01.078.
Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda.
Griffin A, McSorley S
Mucosal Immunol. 2011; 4(4):371-82.
PMID: 21307847
PMC: 4084725.
DOI: 10.1038/mi.2011.2.
Dissemination of persistent intestinal bacteria via the mesenteric lymph nodes causes typhoid relapse.
Griffin A, Li L, Voedisch S, Pabst O, McSorley S
Infect Immun. 2011; 79(4):1479-88.
PMID: 21263018
PMC: 3067558.
DOI: 10.1128/IAI.01033-10.
Early eradication of persistent Salmonella infection primes antibody-mediated protective immunity to recurrent infection.
Johanns T, Law C, Kalekar L, ODonnell H, Ertelt J, Rowe J
Microbes Infect. 2010; 13(4):322-30.
PMID: 21134485
PMC: 3056909.
DOI: 10.1016/j.micinf.2010.11.004.
Innate immune activation during Salmonella infection initiates extramedullary erythropoiesis and splenomegaly.
Jackson A, Nanton M, ODonnell H, Akue A, McSorley S
J Immunol. 2010; 185(10):6198-204.
PMID: 20952675
PMC: 3137927.
DOI: 10.4049/jimmunol.1001198.
B7-H1 (programmed cell death ligand 1) is required for the development of multifunctional Th1 cells and immunity to primary, but not secondary, Salmonella infection.
Lee S, ODonnell H, McSorley S
J Immunol. 2010; 185(4):2442-9.
PMID: 20639491
PMC: 4017671.
DOI: 10.4049/jimmunol.1000743.
Comments to metallothionein as an anti-inflammatory mediator.
Guan Y
Mediators Inflamm. 2009; 2009:426214.
PMID: 19829743
PMC: 2760952.
DOI: 10.1155/2009/426214.